verkazia Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Verkazia, and what generic alternatives are available?
Verkazia is a drug marketed by Harrow Eye and is included in one NDA. There are seven patents protecting this drug.
This drug has one hundred and fifteen patent family members in twenty-three countries.
The generic ingredient in VERKAZIA is cyclosporine. There are eighteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Verkazia
A generic version of verkazia was approved as cyclosporine by HIKMA on October 29th, 1999.
Summary for verkazia
International Patents: | 115 |
US Patents: | 7 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Patent Applications: | 3,365 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for verkazia |
What excipients (inactive ingredients) are in verkazia? | verkazia excipients list |
DailyMed Link: | verkazia at DailyMed |
Pharmacology for verkazia
Drug Class | Calcineurin Inhibitor Immunosuppressant |
Mechanism of Action | Calcineurin Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors |
US Patents and Regulatory Information for verkazia
verkazia is protected by seven US patents and two FDA Regulatory Exclusivities.
Patents protecting verkazia
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: FOR THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS IN CHILDREN AND ADULTS
Emulsion compositions containing quaternary ammonium compounds
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Emulsion compositions containing quaternary ammonium compounds
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Compositions containing quaternary ammonium compounds
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Emulsion compositions containing cetalkonium chloride
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Emulsion compositions containing quaternary ammonium compounds
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
FDA Regulatory Exclusivity protecting verkazia
FOR THE TREATMENT OF VERNAL KERATOCONJUNCTIVITIS (VKC) IN CHILDREN AND ADULTS
Exclusivity Expiration: ⤷ Try a Trial
NEW PRODUCT
Exclusivity Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow Eye | VERKAZIA | cyclosporine | EMULSION;OPHTHALMIC | 214965-001 | Jun 23, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Harrow Eye | VERKAZIA | cyclosporine | EMULSION;OPHTHALMIC | 214965-001 | Jun 23, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Harrow Eye | VERKAZIA | cyclosporine | EMULSION;OPHTHALMIC | 214965-001 | Jun 23, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for verkazia
See the table below for patents covering verkazia around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Portugal | 1809238 | ⤷ Try a Trial | |
South Korea | 101507465 | ⤷ Try a Trial | |
Cyprus | 2017007 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for verkazia
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2049079 | PA2017003,C2049079 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: CIKLOSPORINAS; REGISTRATION NO/DATE: EU/1/15/990 20170319 |
2049079 | PA2017003 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: CIKLOSPORINAS; REGISTRATION NO/DATE: EU/1/15/990 20170319 |
1809237 | 300741 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: CICLOSPORINE (EYE DROP EMULSION); REGISTRATION NO/DATE: EU/1/15/990 20150323 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |